ITeos Therapeutics Inc (NASDAQ:ITOS) shares traded -1.97% lower at $14.95 on Wall Street last session.
ITOS stock price is now 3.92% away from the 50-day moving average and 28.51% away from the 200-day moving average. The market capitalization of the company currently stands at $539.99M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $37, H.C. Wainwright recently initiated with Buy rating for ITeos Therapeutics Inc (NASDAQ: ITOS). On October 08, 2020, Robert W. Baird recently initiated its ‘Outperform’ rating on the stock quoting a target price of $45, while ‘Wedbush’ rates the stock as ‘Outperform’
In other news, Gall Matthew, Chief Financial Officer bought 5,000 shares of the company’s stock on Oct 12 ’23. The stock was bought for $41,850 at an average price of $8.37. Upon completion of the transaction, the Chief Financial Officer now directly owns 19,429 shares in the company, valued at $0.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Aug 23 ’23, Boxer Capital, LLC sold 350,000 shares of the business’s stock. A total of $5,692,673 was realized by selling the stock at an average price of $16.26. This leaves the insider owning 1,804,058 shares of the company worth $26.97 million. A total of 23.37% of the company’s stock is owned by insiders.
During the past 12 months, ITeos Therapeutics Inc has had a low of $8.20 and a high of $18.75. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 13.51, and a quick ratio of 13.51. The fifty day moving average price for ITOS is $14.4408 and a two-hundred day moving average price translates $11.64745 for the stock.
The latest earnings results from ITeos Therapeutics Inc (NASDAQ: ITOS) was released for 2024-03-31.
